Determination of plasma loratadine concentration with RP-HPLC and its pharmacokinetic study
Haiyan Miao
Abstract
Haiyan Miao
Abstract
Objective : To establish a RP-HPLC method for the determination and pharmacokinetic study of loratadine in Chinese healthy volunteers. Methods; Chrornatography was performed on a Hypersil-BDS with acetonitrile-water (65 : 35, pH was adjusted to 3. 8 with H3PO4) as mobile phase. The flow rate was 1. 0 ml/min and the UV wavelength was set at 248 nm. Results: Good linearity was found within 0. 506 0-50. 60 ng/ml of loratadine in human plasma(r = 0. 999 5). The mean relative recovery rate was more than 95% ; intra-day and inter-day RSD were less than 15. 0%. The limit of detection was 0. 506 ng/ml. The main pharmacokinetic parameters were as follows:t12 was (1. 57 ± 0. 18) h;MRT was (2. 46±0. 19) h;Cl/ F was (583. 7±215. 0) L/h;cmax, was (37. 40±8. 92) ng/ml;tmax was (1. 0±0. 20) h;AUC0-8h was (73. 24±21. 30) ng · h/ ml;.AUC/C0-∞ was (75. 57±21. 70) ng · h/ml. Conclusion: Our method has a good selectivity and sensitivity and can be used for further clinical pharmacokinetic study of loratadine.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective : To establish a RP-HPLC method for the determination and pharmacokinetic study of loratadine in Chinese healthy volunteers. Methods; Chrornatography was performed on a Hypersil-BDS with acetonitrile-water (65 : 35, pH was adjusted to 3. 8 with H3PO4) as mobile phase. The flow rate was 1. 0 ml/min and the UV wavelength was set at 248 nm. Results: Good linearity was found within 0. 506 0-50. 60 ng/ml of loratadine in human plasma(r = 0. 999 5). The mean relative recovery rate was more than 95% ; intra-day and inter-day RSD were less than 15. 0%. The limit of detection was 0. 506 ng/ml. The main pharmacokinetic parameters were as follows:t12 was (1. 57 ± 0. 18) h;MRT was (2. 46±0. 19) h;Cl/ F was (583. 7±215. 0) L/h;cmax, was (37. 40±8. 92) ng/ml;tmax was (1. 0±0. 20) h;AUC0-8h was (73. 24±21. 30) ng · h/ ml;.AUC/C0-∞ was (75. 57±21. 70) ng · h/ml. Conclusion: Our method has a good selectivity and sensitivity and can be used for further clinical pharmacokinetic study of loratadine.
Key concepts: Loratadine, Pharmacokinetics, Chromatography, Cmax, Chemistry, High-performance liquid chromatography, Plasma concentration, Pharmacology